Skip to content
Aperlena

Romania - Antithrombotics - Framework supply agreement - Medicines - Caplacizumab

Original România - Antitrombotice - ACORD-CADRU de furnizare produse - Medicamente - CAPLACIZUMABUM

Open Contract notice 9 days left
Watch this tender

Deadline 5 Oct. If it moves, an email when the register sees it. A correction: the same email. Log in

  1. Published
  2. Today
  3. Deadline open for 36 days
  4. Awarded pending

The Aperlena Verdict

Open race

No supplier dominates: 51 different companies have won the last 55 comparable contracts from this buyer over 5 years. This is a genuinely open race.

-94%
Expected final price vs the published estimate

Based on 55 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

The Romanian buyer is procuring supplies of the medicine caplacizumab, indicated for the treatment of acquired thrombotic thrombocytopenic purpura (acquired TTP), through a framework agreement. The product is supplied as a powder plus solvent for injectable solution, 10 mg, in kits containing one vial with 10 mg caplacizumab and one pre-filled solvent syringe for intravenous and subcutaneous administration. Minimum quantities are 90 kits per one-month subsequent contract, 1080 kits over the 12-month framework agreement, with maximums of 270 kits over 3 months and 3240 kits over 36 months. Potential suppliers may bid under the framework agreement procedure.

Description

Obiectul contractului il constituie furnizarea medicamentului caplacizumabum, indicat pentru tratamentul purpurei trombocitopenice trombotice dobândite (PTTd). Denumire Comună Internațională (DCI): Caplacizumabum; - formă farmaceutică: PULB.+SOLV. PT. SOL. INJ.; - Concentrație: 10 mg CAPLACIZUMABUM - pulb.+solv. pt. sol. inj.; 1 flac continand 10 mg caplacizumab si 1 seringa preumpluta cu solvent administrare intravenoasa si subcutanata cant min ctr. subsecvent (1 luna) = 90 kit; cant max ctr. subsecvent (3 luni) = 270 kit cant min acord cadru (12 luni) = 1080 kit cant max acord cadru (36 luni) = 3240 kit

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 weeks ago

More from this buyer

Full buyer profile

5 open tenders right now

Who usually wins this buyer's contracts in this sector

Based on 55 awards with a linked company profile over the last 5 years.

What this buyer has paid before

Based on 45 comparable contracts this buyer awarded in this sector over the last 4 years.

€103,212
Lower quartile
€251,932
Median award
€735,338
Upper quartile

This tender is estimated 4088% above that median

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,072,553
9,852 open across Europe right now 5% above sector average
Buyer track record on Aperlena
105 notices tracked · 78 awarded
€22,664,107 in awarded contracts

Never miss a tender like this

312 new notices in Medical equipment & pharmaceuticals in Romania in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close